Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #Cancer #FDA Approval #Novo Nordisk #Pfizer
Cancer Immunology

A new way to boost the immune cells to fight against cancer cells

  • By Editor's Desk
  • 22 April 2024
immune cell therapy for cancer

To increase the efficacy of treatment, scientists from Virginia Tech’s College of Engineering have created a novel cancer immunotherapy that targets cancer-killing cytokines where they are found in tumours.

Tagged Cancer, Immunotherapy
Research Microbiology

Research: Discovery of a new class of antimicrobials in soil bacteria

  • By Journal Updates
  • 20 April 2024
soil bacteria

For almost a century, researchers have mined Streptomyces for antibiotics; nevertheless, the recently discovered umbrella toxin went unnoticed.

Tagged Antimicrobials, Soil Bacteria
Healthcare & Pharmaceuticals News

FDA-approved epilepsy drug prevents brain tumors in mice with NF1

  • By Journal Updates
  • 18 April 2024
epilepsy brain

Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.

Tagged Brain Tumors, Epilepsy, FDA
Research News

Reduced risks of common diseases through the inherited predisposition for higher muscle strength

  • By Editor's Desk
  • 16 April 2024
muscle strength

An extended life expectancy and a reduced risk of common diseases are predicted by a genetic inclination towards greater muscle strength

Tagged Disease Risks, Muscle Strength
Disease Biology News

A new theory for Parkinson’s disease origin and spread

  • By Editor's Desk
  • 14 April 2024
parkinson's disease

On World Parkinson’s Day, a new hypothesis study combines the body-first and brain-first theories with environmental toxicants that may be consumed or breathed as potential origins of the condition.

Tagged Parkinson's disease
Research

Research: CAR T cell longevity is controlled by the influence of a protein

  • By Journal Updates
  • 11 April 2024
car t cell treatment

CAR T cell therapy allows a patient’s T cells to be reprogrammed to identify and eliminate the cancer cells

Tagged CAR-T Cell, CAR-T Cell Therapy, CRISPR
Research News

Neurodegenerative disease can be triggered by a viral infection; mitochondria have a key role

  • By Editor's Desk
  • 9 April 2024
neurodegenerative disease

An increasing neurodegenerative illness can be brought on by a viral infection, according to research by a multidisciplinary scientific team at the University of Helsinki. The antiviral defence mechanisms’ responsibilities for mitochondria are related to this process.

Tagged mitochondria, Neurodegenerative disease, viral infection
Laboratory Info Biotechnology

Micropipette – An Overview | Working, Parts, Calibration, Types, and Applications

  • By Achuth B S
  • 6 April 2024
micropipette diagram

A classic tool whose capacity to measure and transfer very small quantities of liquid with startling precision has completely changed the field of experimental science.

Tagged Micropipette
Technology

Oxygen journey in the brain can be illuminated by a new imaging technology

  • By Editor's Desk
  • 3 April 2024
brain image

Although it is well established that timely and effective oxygen supply is essential for normal brain function, scientists still don’t fully understand the exact mechanisms involved.

Tagged Brain Imaging, Oxygen Supply
Artificial Intelligence News

New drugs for antibiotic-resistant bacteria, developed using generative AI

  • By Editor's Desk
  • 31 March 2024
new vaccination concept

A new artificial intelligence model called SyntheMol is developed by Stanford Medicine researchers. It generates formulas that chemists may use to synthesize pharmaceuticals in the lab.

Tagged antibiotic resistance, Generative AI

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion
Business CDMO Healthcare & Pharmaceuticals Manufacturing News

Samsung Biologics Q2 2026 Earnings: Revenue Rises to KRW 1,321 Billion Amid Global Manufacturing Expansion

24 July 202624 July 2026
Editor's Desk
Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics
Business Healthcare & Pharmaceuticals News

Danaher Corporation Q2 2026 Financial Results; Strategic Capital Allocation, and Market Valuation Dynamics

23 July 202623 July 2026
BiotechReality Business Intelligence Desk
Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth
Business Healthcare & Pharmaceuticals News

Novartis Q2 2026 Results: Kisqali, Kesimpta, and Pluvicto Drive Return to Sales Growth

22 July 202622 July 2026
BiotechReality Business Intelligence Desk
Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons
Legal and Patent Affairs Healthcare & Pharmaceuticals News

Novo Nordisk Eli Lilly Lawsuit: Novo Nordisk Sues Eli Lilly Over Misleading Wegovy, Ozempic Ad Comparisons

21 July 202622 July 2026
Legal and IP Desk
Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN
Regulatory Approval Healthcare & Pharmaceuticals News

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

18 July 202617 July 2026
Regulatory Intelligence Desk
LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C
Regulatory Approval Healthcare & Pharmaceuticals News

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

17 July 202617 July 2026
Regulatory Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Global Campaign Specialist – Pall Corporation
    23 July 2026
  • Key Account Manager Bioprocess – Cytiva
    20 July 2026
  • Quality Specialist – Thermo Fisher Scientific
    17 July 2026
  • HSE Specialist – Novartis
    17 July 2026
  • Field Application Specialist – Sartorius
    14 July 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter